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INTRODUCTION: TGF-beta-activated kinase-1 (TAK1), a mitogen-activated protein 
kinase, exerts a variety of biophysiological functions through governing numerous 
downstream signalings such as TGF beta, JNK and NFkb depending on the cell types and 
stimulus. Emerging evidences have revealed that TAK1 is significantly involved in 
human cancer progression. However, the functional roles and molecular mechanisms of 
TAK1 in ovarian cancers remain totally obscure. 
 
MATERIALS AND METHODS: Quantitative RT-PCR (Q-PCR) and 
Immunohistochemistry (IHC) analyses were used to evaluate TAK1 expression level in 
human ovarian cancer samples. Stable overexpressing TAK1 was generated by 
transfection of pCMV-HA-TAK and pCMV-FLAG-MAT-Tag-1-TAK1 in ovarian cancer 
cell lines, while knockdown of endogenous TAK1 was established using vector-based 
RNAi constructs in TAK1 overexpressing cell lines. (5Z)-7-Oxozeaenol was used to 
inhibit TAK1 activity. In vitro tumroigenic assays such as cell proliferation, colony 
formation, wound healing, soft agar and cell invasion assays were performed. Western 
blotting was performed to study the molecular mechanism of TAK1 using antibodies p-
TAK1 (Ser412; Thr184/187), TAK1, p-IKK, p-AMPK, AMPK and b-actin. 
 
RESULTS AND DISCUSSION: Q-PCR results showed that TAK1 was significantly 
upregulated (P = 0.005) in clinical ovarian cancer samples (n = 87) as compared with 
normal controls (n = 47). IHC analysis on an ovarian cancer tissue array further proved 
that TAK1 was remarkably upregulated in ovarian cancer samples. Importantly, clinical-
pathological correlation analysis revealed that the overexpressed TAK1 was significantly 
associated with high-grade (P = 0.08), lymph node and distant metastasis (P = 0.025), as 
well as a tendency toward advanced stage ovarian cancers. Functionally, enforced 
expression of TAK1 was able to augment cell proliferation, colony formation, anchorage 
independent growth and migration/invasion in ovarian cancer cells. Conversely, depletion 
of endogenous TAK1 in ovarian cancer cells noticeably abrogated these tumorigenic 
capacities. Similar results were observed by specific inhibition of TAK1 activity by (5Z)-
7-Oxozeaenol. In addition, cotreatment of (5Z)-7-Oxozeaenol could sensitize ovarian 
cancer cells to cisplatin-induced cell apoptosis. Moreover, our data showed that there was 
an increase of Ser412 but not Thr184/187 phosphorylation of TAK1 in ovarian cancer 
cells. Importantly, the increased phsophorylated TAK1 was accompanied by elevated 
expression of phospho-IKK, indicating the activated TAK1 may upregulate NFkB 
signaling activity in ovarian cancer cells. 
 
CONCLUSION: Our findings suggest that the aberrant activation of TAK1 is associated 
with ovarian cancer cell growth, migration/invasion, and chemoresistance and maybe 
through enhancing NFkB signaling activity. Further biochemical studies in delineating 
the functional importance of TAK1 phosphorylation at Ser412 in governing NFkB 
signaling are warranted. 
